To determine whether serum GKN1 protein concentration can be used as a novel biomarker for early detection of gastric cancer, we measured the serum GKN1 protein concentrations in 500 patients with gastric cancer and 200 healthy controls. This evidence concerns the gene GKN1 and gastric cancer.